Advertisement

Topics

Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Revision: 23, Authorised

13:27 EDT 18 Oct 2016 | European Medicines Agency
This article has expired, however you can still download the PDF.
Preview:
...

Other Sources for this Article

Original Article: Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Revision: 23, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Revision: 23, Authorised"

Quick Search
Advertisement